A purple and pink letter v on a white background.
October 19, 2017

Advances in Aesthetic Sun Damage Treatment

Sun damage is among the most frequent reasons patients visit aesthetics practitioners. With sun damage, UV light radiation increases production of free radicals in the skin. This causes damage to DNA, as well as inflammation of the collagen and other proteins that provide elasticity and tone to skin.

Excessive sun exposure leads to the appearance of premature aging in the form of lines, wrinkles, brown or red spots, broken capillaries, and leathery, dry, and/or rough skin. Some people may even develop pre-cancerous lesions or melanoma.

Fortunately, there are many treatments available for sun damage, and new techniques are opening doors for patients in need of advanced aesthetic care.

Anti-Aging Treatments for Sun Damage

Sun exposure degrades collagen and elastin in skin as well, and thus can seriously worsen the appearance of loose skin and wrinkles. Traditional anti-aging treatments, like skin tightening and resurfacing with energy-based devices, can be useful for treating the sagging, deflated appearance associated with sun damaged skin. These treatments use radio frequency technology, which has been proved to be safe for patients with darker skin types.

One treatment gaining greater clinical validation is facial fat transfer, or fat grafting. This entails taking fat cells from one part of the patient’s body and injecting them at the treatment site. This technique is frequently used to reduce the signs of descent and deflation in aging skin that are often worsened by sun damage.

Another anti-aging procedure is microneedling. Also known as collagen induction therapy, this treatment uses miniature needles to produce controlled skin injuries. As the skin heals, it revitalizes elastin and collagen production, making it effective in fighting the signs of aging.

Light and Energy Treating for Sun Damage

Light- and energy-based treatments, like laser or intense pulsed light (IPL), are also commonly used to treat sun damage. Laser treatments have been in use for nearly three decades, though some recent advances in device technology are revealing safer, consistent, and better clinical results.

Laser and IPL are similar in that they both use light energy to target skin cells. They differ in how and what they target in the skin. Typically, lasers will deploy one wavelength and have a solo chromophore (target), such as water. IPL emits several wavelengths, which can target multiple chromophores, such as melanin and oxyhemoglobin. 

IPL treatments can be tailored to suit different patients based on the severity of sun damage, patient skin type, and their response to treatment. However, IPL can be challenging on skin types that are rich in melanin. However, recent advances have allowed for better safety profiles in darker Fitzpatrick skin types.

New Therapeutic Substances

Research is moving swiftly on a variety of novel substances that hold potential for preventing or treating sun damage. Among them is sulforaphane, a natural compound that occurs in cruciferous vegetables, which “demonstrated protective effects against UV-induced skin damage” according to a 2016 study. Another compound is the antioxidant pterostilbene, which is chemically similar to resveratrol and is often found in sources like blueberries. A 2017 study found that pterostilbene “effectively protected against UVB-induced photodamage”.

As well, a combination of extracts from soybean and marine plants that contain a natural carotenoid pigment was recently found to have potential in preventing premature aging symptoms caused by sun damage.

The results highlight the potential for this combination to be developed as a therapeutic agent to prevent skin wrinkling caused by ultraviolet rays. Wrinkling and loose skin, which is often exacerbated by or symptomatic of sun damage, can be treated with energy-based devices using radio frequency technology.

Sun damage can be difficult to avoid. It’s no surprise, then, that sun damage is one of the most common conditions that medical aesthetics professionals encounter. But as treatments continue to evolve, it is more necessary than ever for aesthetic practitioners to stay at the cutting edge of aesthetic innovation.

To learn more about treatment innovations and the latest options for treating sun damage, download our essential free report, New Horizons for Sun Damage Treatment.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.